azd7268
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00796965)
Timeline
Indications
Mechanism of action
- Delta opioid receptorAGONIST
OPRD1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd7268
- azd7268
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01116011 | Phase 1 | Apr 1, 2010 | AstraZeneca, Kitasato University |
| NCT01020799 | Phase 2 | Nov 1, 2009 | AstraZeneca |
| NCT00912353 | Phase 1 | May 1, 2009 | AstraZeneca, California Clinical Trials |
| NCT00861718 | Phase 1 | Apr 1, 2009 | AstraZeneca |
| NCT00796965 | Phase 1 | Dec 1, 2008 | AstraZeneca |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 5 | 5 | 2 | 2008 |
| California Clinical Trials | For profit | 1 | 0 | 1 | 2009 |
| Kitasato University | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1